S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › CRM › Research report
← CRM page
XStocksXray
Research report · 16 October 2026

Salesforce, Inc. (CRM)

Information Technology · Application Software · US stock · price as of 16 Oct 2026

Key indicators

Price$240.70
52-week range$146.06 – $267.80
Market cap$197.6B
P/E (trailing)22.4×
EV / EBITDA22.1×
Free-cash-flow yield7.7%
Dividend yield0.7%
Revenue (last 12 months)$43.9B
Revenue growth (3y a year)9.8%
Operating margin19.9%
Return on invested capital9.9%
Net debt / EBITDA3.0×

Fair value

Blended fair value$153.31 range $145 – $162
Versus priceOvervalued−36% to fair value
Peer multiples$181.15
Fundamentals-adjusted multiple$129.95
10-year DCF (market-scaled)$148.84
Earnings power value (floor, not blended)$11.80
Model uncertaintyHigh

X-Ray Score

49/ 100 · High confidence · ahead of 45% of sector peers
Valuation57
Growth69
Profitability40
Financial health33
Dividends48

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

112178244311377Fair value $1532021-102023-012024-042025-072026-10

Executive summary

Salesforce provides cloud software for managing customer relationships, including sales, service, marketing, commerce and analytics products, as well as the Slack workplace tool and the Tableau data platform. Businesses pay recurring subscription fees to use these applications, and the company also earns revenue from professional services. It has been adding artificial intelligence agents to its products, and acquisitions have been a regular part of its growth.

Over the latest twelve months the company reported revenue of $43.9 billion, with growth of 9.8% a year across three years. It reports an operating margin of 19.9%, with return on invested capital of 10%. Leverage, measured as net debt to EBITDA, is 3.0 times. A dividend is paid, with a yield of 0.7%. These figures describe past results and the present financial position only.

StocksXray gives Salesforce, Inc. an X-Ray Score of 49 out of 100 (high confidence), ahead of 45% of the S&P 500 stocks in its sector. Its strongest lens is growth (69) and its weakest is financial health (33).

Our fair value blend is $153.31 (range $145.36 to $162.23). At $240.70 the stock trades 57% above that blend, so the label is "Overvalued" with high model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Salesforce, Inc. (CRM)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2022FY2023FY2024FY2025FY2026Now
Price$228.27$164.82$275.82$337.17$210.84$240.70
Market cap$222.3B$164.3B$271.4B$328.4B$201.6B$197.6B
P/E154.2×784.9×65.7×53.0×27.0×22.4×
EV / revenue8.4×5.2×7.6×8.5×5.0×5.1×
EV / EBITDA181.4×84.0×43.6×39.3×21.7×22.1×
Price / free cash flow42.1×26.0×28.6×26.4×14.0×13.0×
Free-cash-flow yield2.4%3.8%3.5%3.8%7.1%7.7%
Price / book3.8×2.8×4.6×5.4×3.4×5.1×
Dividend yield–––––0.72%

Fundamentals checklist ● 5 Good · ● 6 Average · ● 5 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−5.6%Average
Free-cash-flow yield7.7%Good

Risk models

Altman Z score1.7×Bad
Piotroski F-Score7 of 9Good

Growth

EPS growth (3y)233.7%Good
Free-cash-flow growth (3y)31.6%Good
Revenue growth (3y)9.8%Average
Growth consistency100%Good

Balance sheet

Current ratio0.8×Bad
Net debt / EBITDA3.0×Bad
Interest cover8.9×Bad

Valuation

Fair value vs price0.6×Average
EBIT / EV yield3.8%Average

Profitability

Return on invested capital9.9%Bad
Operating margin19.9%Average
Gross profitability31.0%Average
stocksxray.com · page 2
XStocksXray
Salesforce, Inc. (CRM)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY22FY23FY24FY25FY26LTM
Revenue26,49231,35234,85737,89541,52543,938
Gross profit19,46622,99226,31629,25232,25533,956
Operating income5481,0305,0117,2058,3318,735
Net income1,4442084,1366,1977,4579,662
Diluted EPS ($)1.480.214.206.367.8010.74
Free cash flow5,2836,3139,49812,43414,40215,154
Gross margin73.5%73.3%75.5%77.2%77.7%77.3%
Operating margin2.1%3.3%14.4%19.0%20.1%19.9%
Net margin5.5%0.7%11.9%16.4%18.0%22.0%
Balance sheetFY22FY23FY24FY25FY26LTM
Total assets95,20998,84999,823102,928112,305109,620
Cash5,4647,0168,4728,8487,3278,310
Total debt10,59610,6019,4268,43314,43939,288
Equity58,13158,35959,64661,17359,14238,378
Dividend per share ($)–––––1.71

Revenue and net income US$ billions: navy revenue, teal net income

FY22FY23FY24FY25FY26

Margins blue gross, teal operating, brown net

0%26%52%78%FY22FY23FY24FY25FY26

Latest quarters

Apr 2025Jul 2025Oct 2025Jan 2026Apr 2026Jul 2026
Revenue ($M)9,82910,23610,25911,20111,13311,345
Growth vs a year earlier+7.6%+9.8%+8.6%+12.1%+13.3%+10.8%
Net income ($M)1,5411,8872,0861,9432,1073,526
Diluted EPS ($)1.591.962.19–2.424.29
stocksxray.com · page 3
XStocksXray
Salesforce, Inc. (CRM)

Peers in Application Software

CompanyX-Ray
CRM · Salesforce, Inc.49
ADBE · Adobe Inc.77
INTU · Intuit Inc.72
FICO · Fair Isaac Corp70
ADSK · Autodesk, Inc.67

Market Compass outlook for Information Technology: Favourable (75/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+5.0%
1 month−0.9%
3 months+38.7%
6 months+32.7%
1 year+2.6%
3 years+18.6%
5 years−10.0%

Technical summary

DailyStrongly bullish12 bullish · 3 neutral · 1 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish
50-day / 200-day average$229.90 / $198.30
52-week low / high$146.06 / $267.80
Classic pivot, support and resistanceS2 228.62 · S1 234.66 · P – · R1 249.34 · R2 257.98

Recent dividends

Ex-dividend dateAmount per share
17 Sep 2026$0.4400
11 Jun 2026$0.4400
9 Apr 2026$0.4400
18 Dec 2025$0.4160
17 Sep 2025$0.4160
18 Jun 2025$0.4160
stocksxray.com · page 4
XStocksXray
Salesforce, Inc. (CRM)

Strengths

  • Free-cash-flow yield of 7.7% is ahead of 88% of its sector peers.
  • Piotroski F-Score of 7 out of 9: most of the nine accounting health tests pass.

Risks and weak spots

  • Altman Z score is weak against Information Technology peers (1.7×).
  • Current ratio is weak against Information Technology peers (0.8×).
  • Net debt / EBITDA is weak against Information Technology peers (3.0×).
  • Interest cover is weak against Information Technology peers (8.9×).
  • Return on invested capital is weak against Information Technology peers (9.9%).
  • The Altman Z score of 1.7× is in the distress zone.
  • The price is above our fair value range, so good news may already be in the price.

Latest SEC filings

DateFormItems
17 Sep 20268-K7.01,9.01
4 Sep 20268-K5.02
27 Aug 202610-Q
26 Aug 20268-K2.02,9.01
5 Aug 20268-K5.02
2 Jun 20268-K5.02
1 Jun 20268-K5.02,9.01
28 May 202610-Q

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026